Thompson Davis & Co’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-369
| Closed | -$52K | – | 1166 |
|
|
2017
Q3 | $52K | Sell |
369
-206
| -36% | -$29K | 0.09% | 230 |
|
|
2017
Q2 | $70K | Buy |
575
+310
| +117% | +$37.7K | 0.11% | 174 |
|
|
2017
Q1 | $32K | Sell |
265
-11
| -4% | -$1.33K | 0.05% | 343 |
|
|
2016
Q4 | $34K | Buy |
276
+37
| +15% | +$4.56K | 0.06% | 318 |
|
|
2016
Q3 | $29K | Buy |
239
+40
| +20% | +$4.85K | 0.05% | 362 |
|
|
2016
Q2 | $23K | Sell |
199
-2
| -1% | -$231 | 0.04% | 427 |
|
|
2016
Q1 | $28K | Sell |
201
-1
| -0.5% | -$139 | 0.04% | 355 |
|
|
2015
Q4 | $39K | Hold |
202
| – | – | 0.06% | 300 |
|
|
2015
Q3 | $32K | Buy |
202
+50
| +33% | +$7.92K | 0.04% | 347 |
|
|
2015
Q2 | $27K | Buy |
152
+29
| +24% | +$5.15K | 0.03% | 466 |
|
|
2015
Q1 | $21K | Buy |
123
+9
| +8% | +$1.54K | 0.03% | 520 |
|
|
2014
Q4 | $21K | Buy |
114
+17
| +18% | +$3.13K | 0.02% | 504 |
|
|
2014
Q3 | $16K | Buy |
+97
| New | +$16K | 0.02% | 543 |
|
|
2014
Q2 | – | Sell |
-24
| Closed | -$4K | – | 897 |
|
|
2014
Q1 | $4K | Sell |
24
-750
| -97% | -$125K | 0.01% | 685 |
|
|
2013
Q4 | $103K | Buy |
+774
| New | +$103K | 0.16% | 150 |
|